The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Potekaev N.N.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology, Moscow, Russia

Vavilov V.V.

MNPTsDK Departament zdravookhraneniia Moskvy;
Pervyĭ MGMU im. I.M. Sechenova

Sobolev V.V.

N.I. Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow

Soboleva A.G.

N.I. Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow

Zolotarenko A.D.

Institut obshcheĭ genetiki im. N.I. Vavilova RAN

Piruzian É.S.

FGBUN Institut obshcheĭ genetiki im. N.I. Vavilova RAN, Moskva

Korsunskaia I.M.

Centre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences

Bruskin S.A.

N.I. Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow

ATF-1, ATF-3 and ATF-4 genes expression in affected skin specimen from patients with morphea

Authors:

Potekaev N.N., Vavilov V.V., Sobolev V.V., Soboleva A.G., Zolotarenko A.D., Piruzian É.S., Korsunskaia I.M., Bruskin S.A.

More about the authors

Read: 1070 times


To cite this article:

Potekaev NN, Vavilov VV, Sobolev VV, et al. . ATF-1, ATF-3 and ATF-4 genes expression in affected skin specimen from patients with morphea. Russian Journal of Clinical Dermatology and Venereology. 2013;11(6):13‑17. (In Russ.)

Recommended articles:

References:

  1. Cotton S.A., Herrick A.L., Jayson M.V., Freemont A.J. TGF beta - a role in systemic sclerosis? J Pathol 1998; 184: 1: 4-6.
  2. Sano Y., Harada J., Tashiro S., Gotoh-Mandeville R., Maekawa T., Ishii S. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-Β signaling. J Biol Chem 1999; 274: 13: 8949-8957.
  3. O'Kane S., Ferguson M.W. Transforming growth factor beta and wound healing. Int J Biochem Cell Biol 1997; 29: 63-78.
  4. Higley H., Persichitte K., Chu S., Waegell W., Vancheeswaran R., Black C. Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon. Arthritis Rheum 1994; 37: 278-288.
  5. Kubo M., Ihn H., Yamane K., Tamaki K. Up-regulated expression of transforming growth factor Β receptors in dermal fibroblasts in skin sections from patients with localized scleroderma. Arthritis Rheum 2001; 44: 731-734.
  6. Chung K.Y., Agarwal A., Uitto J., Mauviel A. An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J Biol Chem 1996; 271: 6: 3272-3278.
  7. Karin M., Liu Z., Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997; 9: 2: 240-246.
  8. Piruzyan E.S., Ishkin A.A., Nikol'skaya T.A. i dr. Sravnitel'nyi analiz molekulyarno-geneticheskikh protsessov pri patogeneze psoriaza i bolezni Krona. Mol biol 2009; 43: 1: 175-179.
  9. Piruzyan E.S., Nikol'skaya T.A., Abdeev R.M., Bruskin S.A. Komponenty transkriptsionnogo faktora AP-1 kak geny-kandidaty, uchastvuyushchie v razvitii psoriaticheskogo protsessa. Mol biol 2007; 41: 1069-1080.
  10. Sobolev V.V., Starodubtseva n.l., Piruzyan A.L. i dr. Sravnitel'noe issledovanie ekspressii genov ATF-3 i ATF-4 v porazhennykh ateroskleroticheskim protsessom sosudakh i v kozhe pri psoriaticheskom protsesse. Byul eksper biol i med 2011; 151: 6: 659-663.
  11. Sano Y., Harada J., Tashiro S., Gotoh-Mandeville R., Maekawa T., Ishii S. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-Β signaling. J Biol Chem 1999; 274: 8949-8957.
  12. Yin X., Wolford C.C., Chang Y.S., McConoughey S.J., Ramsey S.A. et al. ATF3, an adaptive-response gene, enhances TGF(beta) signaling and cancer-initiating cell features in breast cancer cells. J Cell Sci 2010; 123: 3558-3565.
  13. Kulski J., Kenworthy W., Bellgard M. et al. Gene expression profiling of Japanese psoriatic skin reveals an increased activity in molecular stress and immune response signals. J Mol Med 2005; 85: 964-975.
  14. Sonkoly E., Wei T., Janson P. et al. MicroRNAs: novel regulators involved in the pathogenesis of Psoriasis? PLoS One 2007; 2: 7: e610.
  15. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 4: 402-408.
  16. Yao Y., Richman L., Morehouse C. et al. Type I interferon: potential therapeutic target for psoriasis? PLoS One 2008; 3: 7: e2737.
  17. Markovics J.A., Araya J., Cambier S., Somanath S., Gline S., Jablons D., Hill A., Wolters P.J., Nishimura S.L. Interleukin-1beta induces increased transcriptional activation of the transforming growth factor-beta-activating integrin subunit beta8 through altering chromatin architecture. J Biol Chem 2011; 286: 42: 36864-36874.
  18. Harding H., Zhang Y., Zeng H., Novoa I., Lu P., Calfon M., Sadri N., Yun C., Popko B., Paules R., Stojdl D., Bell J., Hettmann T., Leiden J, Ron D. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 2003; 11: 619-633.
  19. Tanjore H., Blackwell T.S., Lawson W.E. Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2012; 302: L721-L729.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.